Reuters logo
BRIEF-Financial milestone achieved in Catalyst's subcutaneous factor IX program
2017年7月6日 / 中午12点08分 / 5 个月前

BRIEF-Financial milestone achieved in Catalyst's subcutaneous factor IX program

July 6 (Reuters) - Catalyst Biosciences Inc:

* Financial milestone achieved in Catalyst’s subcutaneous factor IX program

* Catalyst Biosciences Inc - achieved a financial milestone under its collaboration with ISU ABXIS

* Catalyst Biosciences Inc - ISU ABXIS and Catalyst plan to have top-line data from clinical trial by end of 2017 for CB 2679d/ISU304 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below